Dossier
AI drug discovery
Coverage of AI drug discovery in the Nexus archive.
- Jim Cramer's top 10 things to watch in the stock market Monday
Semiconductor stocks are rising, and Bristol Myers is purchasing new Nvidia chips for AI-driven drug discovery.
- OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
OpenAI researcher Miles Wang is in talks to launch a $2 billion AI drug discovery startup. The funding discussions highlight investor interest in using AI for breakthroughs in life sciences.
- Reid Hoffman is leaving Microsoft’s board to go ‘founder mode’ with startup Manus
Reid Hoffman is leaving Microsoft’s board after a profitable decade to focus on his AI drug discovery startup Manus. The move shifts his attention to the startup's operations.